DENTSPLY SIRONA (XRAY) Expands Midwest Deal As Fair Value Narrative Stays In Focus

Event overview and why it matters for DENTSPLY SIRONA

DENTSPLY SIRONA (XRAY) expanded its relationship with Midwest Dental Equipment & Supply, which will start offering the company’s technology portfolio in the United States from 1 November 2026.

The agreement extends a long running consumables focused partnership into digital equipment and connected solutions, using Midwest Dental’s sales, service, and technical teams to widen access for dental practices.

DENTSPLY SIRONA’s recent client announcements come against a tougher share price backdrop, with the stock down 24.96% on a 30-day share price return and the 1-year total shareholder return declining 30.02%, which points to fading momentum despite ongoing commercial rollouts.

Scan where DENTSPLY SIRONA’s recent pressure and distribution push might rhyme with other opportunities by reviewing the hand picked 29 high quality undervalued stocks.

DENTSPLY SIRONA’s expanding distribution network sits against a share price that has retreated hard. Is this move pricing in business issues, or has sentiment simply swung further than the fundamentals suggest?

Most Popular Narrative: 36% Undervalued

The most followed storyline on DENTSPLY SIRONA values the stock at $13.40 using a 9.46% discount rate, compared with the last close at $8.54, which frames the current sell off against a longer runway for execution on digital dentistry and margin repair.

DENTSPLY SIRONA is leveraging the increasing global demand for advanced dental care, driven by an aging population and rising middle class in emerging markets, by ramping up investments in product innovation and tailored field support, which is expected to accelerate international revenue growth over the long term.

The company's continued expansion of digital dentistry platforms (such as DS Core) and emphasis on integrated software/hardware solutions aim to capture higher-margin recurring revenues as dental practices adopt digital workflows, supporting sustainable improvements in net margins and earnings.

See why 10 investors see DENTSPLY SIRONA as 36% undervalued.

Result: Fair Value of $13.40 (UNDERVALUED)

Still, there is a real risk that ongoing revenue pressure and tariff related cost headwinds will disrupt the DENTSPLY SIRONA margin repair story that investors are watching.

Find out about the key risks to this DENTSPLY SIRONA narrative.

Next Steps

If the overall tone on DENTSPLY SIRONA feels mixed, use that as a prompt to check the numbers yourself and move quickly while views are split. Then pressure test whether the optimism around its upside stacks up against the 3 key rewards.

Looking for more DENTSPLY SIRONA style investment ideas?

You do not need to stop with DENTSPLY SIRONA. Let the same disciplined process guide you toward fresh ideas that could fit your portfolio next.

• Target value first and see which companies combine quality fundamentals with a potential markdown through the 29 high quality undervalued stocks.
• Prioritize resilience by filtering for businesses with stronger financial footing using the list of solid balance sheet and fundamentals (25 results).
• Hunt for under followed potential by scanning the 20 high quality undiscovered gems before the crowd catches on.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com